SNOA
$2.40
Sonoma Pharmaceuticals, Inc.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America...
Recent News
Despite Fast-paced Momentum, Sonoma Pharmaceuticals (SNOA) Is Still a Bargain Stock
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Sonoma Pharmaceuticals (SNOA) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Sonoma Pharmaceuticals Soars 95% After Walmart, Amazon Retail Debut
Walmart, Amazon Deal Sends Sonoma Pharmaceuticals Stock Into Frenzy
BC-Most Active Stocks
Nu Holdings Ltd. 57,985,829 12.32
Sonoma Pharmaceuticals (SNOA) Is Attractively Priced Despite Fast-paced Momentum
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Sonoma Pharmaceuticals (SNOA) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
The early winner in the 'Dexit' war for corporate relocations: Nevada
Companies from Andreessen Horowitz to Pershing Square are choosing Nevada as they follow Elon Musk's exit from Delaware.